News | December 13, 2023
Pfizer receives regulatory approvals to complete the acquisition of Seagen
Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and execution
Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and execution
C-CAR031 is based on a novel GPC3-targeting CAR-T (AZD5851) designed by AstraZeneca using their transforming growth factor-beta receptor II
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
The agreement includes an upfront payment of US$15 million, regulatory and commercial milestones, and royalties
First-in-class AKT inhibitor has potential to reshape treatment for breast cancer patients
Merck to pay Daiichi Sankyo a $4 billion upfront payment in addition to $1.5 billion in continuation payments over the next 24 months
Animations, colors, and shapes help to improve poor situational awareness, which is responsible for 81.5% of anesthesia-related errors
Astria will assume full cost and responsibility for the global development and commercialization of the licensed therapeutic program for all indications
Two-year partnership focused on advocacy, education, and raising awareness of stroke as a global healthcare challenge
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
Subscribe To Our Newsletter & Stay Updated
